Direct-acting oral anticoagulants in antiphospholipid syndrome
Antiphospholipid syndrome is an acquired autoimmune thrombophilia characterized by the development of recurrent vascular thrombosis of any caliber and type or obstetric pathology and the mandatory identification of persistently positive antiphospholipid antibodies. The main drug in the treatment of...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2021-01-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2972 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839568215607345152 |
|---|---|
| author | T. M. Reshetnyak K. S. Nurbaeva |
| author_facet | T. M. Reshetnyak K. S. Nurbaeva |
| author_sort | T. M. Reshetnyak |
| collection | DOAJ |
| description | Antiphospholipid syndrome is an acquired autoimmune thrombophilia characterized by the development of recurrent vascular thrombosis of any caliber and type or obstetric pathology and the mandatory identification of persistently positive antiphospholipid antibodies. The main drug in the treatment of patients with antiphospholipid syndrome is warfarin. The role of direct-acting oral anticoagulants in the treatment of antiphospholipid syndrome remains controversial. The article discusses modern data on the place of direct-acting oral anticoagulants in the treatment of antiphospholipid syndrome. |
| format | Article |
| id | doaj-art-0d73f26a6ed244ddacd25f1fc9da68ed |
| institution | Matheson Library |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2021-01-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-0d73f26a6ed244ddacd25f1fc9da68ed2025-08-04T17:04:00ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922021-01-0158670871510.47360/1995-4484-2020-708-7152669Direct-acting oral anticoagulants in antiphospholipid syndromeT. M. Reshetnyak0K. S. Nurbaeva1V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian FederationV.A. Nasonova Research Institute of RheumatologyAntiphospholipid syndrome is an acquired autoimmune thrombophilia characterized by the development of recurrent vascular thrombosis of any caliber and type or obstetric pathology and the mandatory identification of persistently positive antiphospholipid antibodies. The main drug in the treatment of patients with antiphospholipid syndrome is warfarin. The role of direct-acting oral anticoagulants in the treatment of antiphospholipid syndrome remains controversial. The article discusses modern data on the place of direct-acting oral anticoagulants in the treatment of antiphospholipid syndrome.https://rsp.mediar-press.net/rsp/article/view/2972antiphospholipid syndromedirect-acting oral anticoagulantsantiphospholipid antibodiesthrombosisanticoagulants |
| spellingShingle | T. M. Reshetnyak K. S. Nurbaeva Direct-acting oral anticoagulants in antiphospholipid syndrome Научно-практическая ревматология antiphospholipid syndrome direct-acting oral anticoagulants antiphospholipid antibodies thrombosis anticoagulants |
| title | Direct-acting oral anticoagulants in antiphospholipid syndrome |
| title_full | Direct-acting oral anticoagulants in antiphospholipid syndrome |
| title_fullStr | Direct-acting oral anticoagulants in antiphospholipid syndrome |
| title_full_unstemmed | Direct-acting oral anticoagulants in antiphospholipid syndrome |
| title_short | Direct-acting oral anticoagulants in antiphospholipid syndrome |
| title_sort | direct acting oral anticoagulants in antiphospholipid syndrome |
| topic | antiphospholipid syndrome direct-acting oral anticoagulants antiphospholipid antibodies thrombosis anticoagulants |
| url | https://rsp.mediar-press.net/rsp/article/view/2972 |
| work_keys_str_mv | AT tmreshetnyak directactingoralanticoagulantsinantiphospholipidsyndrome AT ksnurbaeva directactingoralanticoagulantsinantiphospholipidsyndrome |